Heterofucan from Sargassum filipendula induces apoptosis in HeLa cells

Fucan is a term used to denominate a family of sulfated polysaccharides rich in sulfated L-fucose. Heterofucan SF-1.5v was extracted from the brown seaweed Sargassum filipendula by proteolytic digestion followed by sequential acetone precipitation. This fucan showed antiproliferative activity on Hel...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Costa, Leandro Silva, Telles, Cinthia Beatrice Silva, Oliveira, Ruth Medeiros, Nobre, Leonardo Thiago Duarte Barreto, Dantas-Santos, Nednaldo, Câmara, Rafael Barros Gomes da, Costa, Mariana Santana Santos Pereira, Almeida-Lima, Jailma, Melo-Silveira, Raniere Fagundes, Albuquerque, Ivan Rui Lopes, Leite, Edda Lisboa, Rocha, Hugo Alexandre de Oliveira
Formato: article
Idioma:English
Publicado em: MDPI
Assuntos:
Endereço do item:https://repositorio.ufrn.br/handle/123456789/31327
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
Descrição
Resumo:Fucan is a term used to denominate a family of sulfated polysaccharides rich in sulfated L-fucose. Heterofucan SF-1.5v was extracted from the brown seaweed Sargassum filipendula by proteolytic digestion followed by sequential acetone precipitation. This fucan showed antiproliferative activity on Hela cells and induced apoptosis. However, SF-1.5v was not able to activate caspases. Moreover, SF-1.5v induced glycogen synthase kinase (GSK) activation, but this protein is not involved in the heterofucan SF-1.5v induced apoptosis mechanism. In addition, ERK, p38, p53, pAKT and NFκB were not affected by the presence of SF-1.5v. We determined that SF-1.5v induces apoptosis in HeLa mainly by mitochondrial release of apoptosis-inducing factor (AIF) into cytosol. In addition, SF-1.5v decreases the expression of anti-apoptotic protein Bcl-2 and increased expression of apoptogenic protein Bax. These results are significant in that they provide a mechanistic framework for further exploring the use of SF-1.5v as a novel chemotherapeutics against human cervical cancer